Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3911 ARTÍCULOS , VIENDO DEL 646 AL 660

Diquat causes caspase-independent cell death in SH-SY5Y cells by production of ROS independently of mitochondria

Nisar R, Hanson PS, He L, Taylor RW, Blain PG, Morris CM.

Arch Toxicol. 2015 Oct;89(10):1811-25. doi: 10.1007/s00204-015-1453-5. Epub 2015 Feb 19.

Effects of slow repetitive transcranial magnetic stimulation in patients with corticobasal syndrome

Civardi C, Pisano F, Delconte C, Collini A, Monaco F.

Neurol Sci. 2015 Jun;36(6):1007-9. doi: 10.1007/s10072-015-2115-3. Epub 2015 Feb 19.

Multitarget network strategies to influence memory and forgetting: the Ras/MAPK pathway as a novel option

Gyurkó MD, Steták A, Sőti C, Csermely P.

Mini Rev Med Chem. 2015;15(8):696-704. doi: 10.2174/1389557515666150219144336.

Systematic review and meta-analysis of Japanese familial Alzheimer's disease and FTDP-17

Kasuga K, Kikuchi M, Tokutake T, Nakaya A, Tezuka T, Tsukie T, Hara N, Miyashita A, Kuwano R, Ikeuchi T.

J Hum Genet. 2015 May;60(5):281-3. doi: 10.1038/jhg.2015.15. Epub 2015 Feb 19.

Targeting histone deacetylases: a novel approach in Parkinson's disease

Sharma S, Taliyan R.

Parkinsons Dis. 2015;2015:303294. doi: 10.1155/2015/303294. Epub 2015 Jan 28.

Is lithium a neuroprotective agent?

Vo TM, Perry P, Ellerby M, Bohnert K.

Ann Clin Psychiatry. 2015 Feb;27(1):49-54.

Safety of IPX066 , an extended release carbidopa-levodopa formulation, for the treatment of Parkinson's disease

Kestenbaum M, Fahn S.

Expert Opin Drug Saf. 2015 May;14(5):761-7. doi: 10.1517/14740338.2015.1015986. Epub 2015 Feb 19.

Pathologic and therapeutic implications for the cell biology of parkin

Charan RA, LaVoie MJ.

Mol Cell Neurosci. 2015 May;66(Pt A):62-71. doi: 10.1016/j.mcn.2015.02.008. Epub 2015 Feb 17.

Alterations in neuronal activity in basal ganglia-thalamocortical circuits in the parkinsonian state

Galvan A, Devergnas A, Wichmann T.

Front Neuroanat. 2015 Feb 5;9:5. doi: 10.3389/fnana.2015.00005. eCollection 2015.

Molecular mechanisms underlying PINK1 and Parkin catalyzed ubiquitylation of substrates on damaged mitochondria

Koyano F, Matsuda N.

Biochim Biophys Acta. 2015 Oct;1853(10 Pt B):2791-6. doi: 10.1016/j.bbamcr.2015.02.009. Epub 2015 Feb 18.

The effectiveness of screening history, physical exam, and ECG to detect potentially lethal cardiac disorders in athletes: a systematic review/meta-analysis

Harmon KG, Zigman M, Drezner JA.

J Electrocardiol. 2015 May-Jun;48(3):329-38. doi: 10.1016/j.jelectrocard.2015.02.001. Epub 2015 Feb 8.

Nanoparticle technology for treatment of Parkinson's disease: the role of surface phenomena in reaching the brain

Leyva-Gómez G, Cortés H, Magaña JJ, Leyva-García N, Quintanar-Guerrero D, Florán B.

Drug Discov Today. 2015 Jul;20(7):824-37. doi: 10.1016/j.drudis.2015.02.009. Epub 2015 Feb 17.

From molecule to molecule and cell to cell: prion-like mechanisms in amyotrophic lateral sclerosis

Grad LI, Fernando SM, Cashman NR.

Neurobiol Dis. 2015 May;77:257-65. doi: 10.1016/j.nbd.2015.02.009. Epub 2015 Feb 17.

The endosomal pathway in Parkinson's disease

Perrett RM, Alexopoulou Z, Tofaris GK.

Mol Cell Neurosci. 2015 May;66(Pt A):21-8. doi: 10.1016/j.mcn.2015.02.009. Epub 2015 Feb 19.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias